Dextran 40 and Methylphenidate Extended-Release Oral Suspension
Determining the interaction of Dextran 40 and Methylphenidate Extended-Release Oral Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextran, low molecular weight
Brand name: LMD
Synonyms: n.a.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextran 40-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Dextran 40-Methylphenidate Extended-Release Tablets
- Dextran 40-Methylphenidate Hydrochloride
- Dextran 40-Methylphenidate LA Capsules
- Dextran 40-Methylphenidate Oral Solution
- Dextran 40-Methylphenidate Oral, Transdermal
- Methylphenidate Extended-Release Oral Suspension-Dextran 70 6% in 5% Dextrose high molecular weight
- Methylphenidate Extended-Release Oral Suspension-Dextran 75
- Methylphenidate Extended-Release Oral Suspension-Dextran high molecular weight
- Methylphenidate Extended-Release Oral Suspension-Dextranomer and Hyaluronate Derivatives (Deflux)
- Methylphenidate Extended-Release Oral Suspension-Dextranomer and Hyaluronate Derivatives (Solesta)
- Methylphenidate Extended-Release Oral Suspension-Dextranomer and sodium hyaluronate